Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Limaprost alfadex and Gabapentin in cervical myelopathy
TCTR20230603001Phase 3Completed
- Sponsor
- Rajavithi Hospital
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of limaprost, gabapentin in cervical myelopathy, sponsored by Rajavithi Hospital. Started Jan 2022; status: completed.
02
Drugs
limaprostgabapentin
03
Conditions
cervical myelopathy
Beyond the preview
Go deeper on TCTR20230603001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230603001.